Clinical trial
Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV
NCT00247884 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00247884 |
|---|---|
| Title | Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV |
| Official title | Directly Observed Therapy for the Treatment of Hepatitis C Virus Infection in Injection Drug Users |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis C Virus Infection |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| Completion | Oct 1, 2009 |
| First posted | Nov 2, 2005 |
| Last update posted | Oct 14, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: